| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/24/2005 | CN1659147A Pyridazine derivatives |
| 08/24/2005 | CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 08/24/2005 | CN1659143A Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity |
| 08/24/2005 | CN1658906A Mycoplasma polypeptides |
| 08/24/2005 | CN1658893A G-type peptides to ameliorate atherosclerosis |
| 08/24/2005 | CN1658888A Quaternised ammonium cyclodextrin compounds |
| 08/24/2005 | CN1658886A Hormone replacement therapy |
| 08/24/2005 | CN1658885A Hormone replacement therapy |
| 08/24/2005 | CN1658884A Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 08/24/2005 | CN1658877A Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 08/24/2005 | CN1658865A Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 08/24/2005 | CN1658863A Severe sepsis preventive therapeutic agent |
| 08/24/2005 | CN1658845A Stealth lipid nanocapsules, methods for the preparation thereof, and use thereof as a carrier for active principle(s) |
| 08/24/2005 | CN1658844A Low dose liquid entecavir formulations and use |
| 08/24/2005 | CN1658828A Gallocatechin gallate-containing composition |
| 08/24/2005 | CN1658767A Composition for modulating a physiological reaction or inducing an immune response |
| 08/24/2005 | CN1658759A Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems |
| 08/24/2005 | CN1657626A Antifungal polypeptide and its preparation method |
| 08/24/2005 | CN1657541A Process for preparating specificity complex IgY of anti coxsackie virus myocarditis and its compound preparation |
| 08/24/2005 | CN1657535A Rutin ester compounds |
| 08/24/2005 | CN1657534A Penthorum seponin (PCPTS) and its antihepatitis and antimutation aetion |
| 08/24/2005 | CN1657102A SARS-Cov gene vaccine based on epi-position and its contruction |
| 08/24/2005 | CN1657097A Action of transfer factor for anti Aids virus |
| 08/24/2005 | CN1657096A Use of korean thistle antibacterial agent-korean thistle extract and its production method |
| 08/24/2005 | CN1657082A Oral Chinese medicinal composition for treating virus myocarditis |
| 08/24/2005 | CN1657072A Special effect medicine for treating split of hand and foot break (rhagades of hand and foot) and tinea of hand and foot |
| 08/24/2005 | CN1657047A Formula of calebassine dripping pills and its preparation method |
| 08/24/2005 | CN1657046A Powder injection composed of sodium cefoperazone and potassium clavulanate |
| 08/24/2005 | CN1657045A Antibacterial medicinal composite containing bota-lactanase inhibitor |
| 08/24/2005 | CN1657043A Formula of lianbizhi preparation and its preparation method |
| 08/24/2005 | CN1216075C Hepatitis C virus high change region 1 synthetic peptide and its use |
| 08/24/2005 | CN1216064C Process for preparing 6-0-substituted erythromycin derivatives |
| 08/24/2005 | CN1216062C Nucleotide analog composation |
| 08/24/2005 | CN1216050C 5,6,7-trinor -4,8-inter-m-phenylene PGI2 derivative and drugs containing the same |
| 08/24/2005 | CN1216034C Malic acid addition salts of terbinafine |
| 08/24/2005 | CN1215884C Chinese medicine formula for preventing common cold by fumigating air to act respiratory tract and using method |
| 08/24/2005 | CN1215879C 人类sars冠状病毒受体抑制剂 Human sars coronavirus receptor inhibitors |
| 08/24/2005 | CN1215878C Composite hepatitis B vaccine for treatment and its preparation method |
| 08/24/2005 | CN1215877C Recombined human interleukin-2 injection and preparing method thereof |
| 08/24/2005 | CN1215870C Method for extracting tenuifolia volatile oil and for treating cold and preparation method of preparation |
| 08/24/2005 | CN1215867C Broad-spectrum anti-inflammatory, antiviral Chinese medicine preparation and preparing method thereof |
| 08/24/2005 | CN1215861C Xiasangju effervescent tablet and its preparing process |
| 08/24/2005 | CN1215858C Medicine for preventing and treating diseases of prawn and preparation method thereof |
| 08/24/2005 | CN1215849C Method for preparing baicalin liquid |
| 08/24/2005 | CN1215843C 黄藤素粉针剂 Palmatine powder |
| 08/24/2005 | CN1215828C Synergistic antiplaque/antigivitis oral composition |
| 08/24/2005 | CN1215765C Hydroxystilbene compounds used as microbicidal active substances |
| 08/23/2005 | US6933313 Carbazoles with hydroxyfunctional amide (hydroxamic or esters) are for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock |
| 08/23/2005 | US6933306 Anticancer agents; antiinflammatory agents; autoimmune disease |
| 08/23/2005 | US6933305 Amide compounds and use thereof |
| 08/23/2005 | US6933303 Antidiabetic agents |
| 08/23/2005 | US6933279 Peptides comprising a class A amphipathic helix when formulated with "D" amino acid residue(s) and/or having protected amino and carboxyl termini |
| 08/23/2005 | US6933129 Method for culturing and assaying cells |
| 08/23/2005 | US6933113 Modulation of endogenous gene expression in cells |
| 08/23/2005 | US6932973 Peptides which stimulate the expression of the cytokines of inflammation and promote tissue regeneration |
| 08/23/2005 | US6932972 Combined vaccine compositions |
| 08/23/2005 | US6932960 Complexes with radionuclides; for use as contrast agent in magnetic resonance imaging (MRI); as parasiticide, viricide, or as chelation therapy of iron overload such as thalassemia; optimal combination of lipophilicity and hydrophilicity |
| 08/23/2005 | CA2469592C Hiv integrase inhibitors |
| 08/23/2005 | CA2266884C Inhibition of 26s and 20s proteasome by indanones |
| 08/23/2005 | CA2186044C Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
| 08/23/2005 | CA2185883C The use of dimeticone as a transport and carrier system and/or drug delivery system |
| 08/23/2005 | CA2119006C Composition and method of treating hepatitis c |
| 08/23/2005 | CA2111571C Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 08/23/2005 | CA2109161C Substituted 1-h-3-aryl-pyrrolidine-2,4-dione derivatives |
| 08/23/2005 | CA2094464C Mutant respiratory syncytial virus (rsv) vaccines containing same and methods of use |
| 08/19/2005 | CA2458026A1 Antifungal and/or antimycotic external preparation for nail |
| 08/18/2005 | WO2005075495A1 6-o-substituted ketolide derivatives |
| 08/18/2005 | WO2005074968A2 Medical use of basic peptides |
| 08/18/2005 | WO2005074909A1 Combination drug |
| 08/18/2005 | WO2005058888A3 Oxazolidinone-quinolone hybrid antibiotics |
| 08/18/2005 | WO2005001096A8 Vaccines against sars |
| 08/18/2005 | WO2004098636A8 Vaccinating against infectious diseases using proteosomes |
| 08/18/2005 | WO2003004608A3 Drug metabolizing enzymes |
| 08/18/2005 | US20050182142 1,2-alkanediol, and citral, geraniol, nerol, perillaldehyde, alpha -terpineol, dodecanol and/or L-carvone |
| 08/18/2005 | US20050182137 Bacterial enzyme inhibitors |
| 08/18/2005 | US20050182130 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 08/18/2005 | US20050182120 Fungicides, microbiocides |
| 08/18/2005 | US20050182112 3-[4-(3,6-dihydro-2H-thiopyran-4-yl) phenyl]-]5[1H or 2H-1,2,3-triazol-1 or 2-yl] oxazolidin-2-ones; grampositive bactericides for drug resistant bacteria, especially Staphylococcus, Enterococcus, and Streptococcus |
| 08/18/2005 | US20050182101 Prodrugs of proton pump inhibitors |
| 08/18/2005 | US20050182094 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens |
| 08/18/2005 | US20050182080 Therapeutic compounds |
| 08/18/2005 | US20050182052 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazinecarboxylic acid derivative effective against resistant bacterium |
| 08/18/2005 | US20050182040 Benzamide derivatives |
| 08/18/2005 | US20050182019 Phosphonate compounds |
| 08/18/2005 | US20050182017 Immunostimulatory nucleic acid molecules |
| 08/18/2005 | US20050182010 Use of a nucleotide construct stably integrated in the genome of the target cells of the virus, which is able to produce a single transcript or multiple transcripts capable of forming a double-stranded RNA which inhibits replication of the virus |
| 08/18/2005 | US20050181999 Comprising a biologically active agent (e.g., antifungal) , urea and an acid (lactic acid) or ethoxydiglycol; provide better bioavailability of the active agent within the nail |
| 08/18/2005 | US20050181998 Prion inhibiting peptides and derivatives thereof |
| 08/18/2005 | US20050181988 antifungal, inhibitory activity on beta -1,3-glucan synthase, treatment of Pneumocystis carinii infection |
| 08/18/2005 | US20050181439 Streptococcus pneumoniae antigens and vaccines |
| 08/18/2005 | US20050181419 For detection of Mycobacterium tuberculosis infection |
| 08/18/2005 | US20050181357 Nucleotide sequences comprisied of spike and nucleocapsid coding sequence for use as amplification tool in detection of coronaviral infection |
| 08/18/2005 | US20050181072 Use of essential oils for combating gi tract infection by helicobacter-like organisms |
| 08/18/2005 | US20050181063 Biologically active agent being encapsulated within microspheres which comprise a polymer which has a molecular weight in excess of 94 kDa and a maximum diameter of 20 mu m; for the intra-nasal administration of vaccines in a single shot vaccination |
| 08/18/2005 | US20050181039 Micelles |
| 08/18/2005 | US20050180993 Assays for the identification of compounds that inhibit assembly of nucleoprotein (NP), virion-associated proteins VP35, and VP24, or inhibit the glycosylation of NP, required for nucleocapsid formation, for use as anti-viral agents |
| 08/18/2005 | US20050180987 Method of separating protective components of bordetella pertussis |
| 08/18/2005 | US20050180985 Live attenuated salmonella strains for producing monovalent or multivalent vaccines |
| 08/18/2005 | US20050180973 TREM-1 splice variant for use in modifying immune responses |
| 08/18/2005 | US20050180963 Probiotic propionibacterium |